Comparing two methods for weight loss after gastric bypass
Official title: Comparing Outcomes of Classic Transoral Outlet Reduction (TORe) Versus Endoscopic Submucosal Dissection-TORe: A Randomized Controlled Trial
Run by The Cleveland Clinic · NCT06131281 · Data updated 2026-11-12
This study is testing two different ways to help people who have gained weight after gastric bypass surgery lose weight again, to see which method works better and is safer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | October 2, 2023 |
| Main results expected | April 2028 |
| Study ends | April 2029 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT06131281 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with a history of Roux-en-Y gastric bypass who have experienced weight regain and have a dilated gastrojejunal anastamosis.
✕Probably not a fit
Patients who have had prior revisions of gastric bypass or have active gastrointestinal conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare two variations of the Transoral Outlet Reduction (TORe) procedure for patients who have regained weight after Roux-en-Y gastric bypass. The study will evaluate the effectiveness and safety of the E-TORe method, which incorporates endoscopic submucosal dissection, against the traditional c-TORe method that uses argon plasma coagulation. Participants will undergo one of the two procedures, and outcomes will be assessed to determine which method leads to greater weight loss and fewer complications. The trial is designed to provide insights into optimizing weight loss interventions for this patient population.
Why it matters
Potential benefit: If successful, this study could lead to more effective and safer weight loss options for patients who have regained weight after gastric bypass surgery.
How similar studies have gone: Previous studies have shown that the traditional c-TORe method results in significant weight loss, but the E-TORe method is a newer approach that has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with history of Roux-en-Y gastric bypass and weight regain * Dilated gastrojejunal anastamosis as diagnosed on endoscopy * Patients undergoing standard of care for treatment of obesity with endoscopic revisional procedure (a.k.a. TORe) who are enrolled in the GI Bariatric Endoscopy program and clinic at the study site Exclusion Criteria: * Prior revision of gastric bypass * Active and uncontrolled gastro-esophageal reflux disease defined as ≥ grade C esophagitis * Active untreated Helicobacter pylori infection * Malignancy newly diagnosed by endoscopy * Upper gastro-intestinal conditions such as ulcers, polyps, gastric varices, strictures, congenital or acquired intestinal telangiectasia or other abnormalities that preclude completion of TORe * Presence of gastrogastric or gastroenteric fistula * Inability to undergo general anesthesia * Participating in another ongoing clinical trial of an investigational weight loss drug or device * Active pregnancy * Use of anticoagulation therapy or P2Y12 inhibitors which cannot be discontinued for the time frame surrounding the procedure * Insulin-dependent diabetes mellitus * Unwillingness to comply with standard post-TORe dietary guidelines and follow-up care * Any other anatomical, technical or otherwise factor that limits the ability of the endoscopist to perform either E-TORe or c-TORe * Any additional factor, which in the investigator's opinion, might jeopardize the subject's safety or compliance with the trial protocol
Where it's running
-
Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Stephen Firkins, MD — The Cleveland Clinic
- Study coordinator: Stephen Firkins, MD
- Email: bariatricendoscopy@ccf.org
- Phone: 2164448460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-intensity interval exercise to support brain activity and weight maintenance
This trial will test whether a 12-week high-intensity interval training (HIIT) program changes brain activity and helps with weight maintenance in adults 18–70, including people who regained weight after bariatric surgery.
-
Evaluating tirzepatide for treating obesity in adolescents
This study is testing if tirzepatide can help teenagers with obesity lose weight and improve their heart health while they follow a healthy eating and exercise program.
-
Obesity prevention program for high-risk infants
This study is testing a parenting program to help prevent obesity in infants from low-income or minority communities during regular doctor visits.
-
Understanding how sleep affects metabolism and weight gain
This study is testing how not getting enough sleep and the timing of sleep can affect metabolism and weight gain in people.
-
Effects of exercise on fat tissue in obese individuals
This study tests how exercise affects fat tissue in people with obesity to see if it can help improve their metabolism and manage weight better.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.